NCT06828640View on ClinicalTrials.gov

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer PatientsVaginal Atrophy Patients With GSMTreatmentSexual DisfunctionDyspareunia (Female)
Interventions
DEVICE

vaginal dilators

Evaluate the efficacy of vaginal dilators as an addition to Standard of Care in premenopausal or menopausal women, including breast cancer survivors

Trial Locations (1)

1000

RECRUITING

Saint Pierre University Hospital Center, Brussels

All Listed Sponsors
lead

Centre Hospitalier Universitaire Saint Pierre

OTHER